Skip to content

Sickle Cell Anemia and Cerebral Microcirculation : Multimodal Exploration

Determinants of Cerebral Oxygenation and Perfusion in SCA Children Based on Combined ASL MRI, NIRS and Hemorheological Investigation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02909283
Acronym
DREAM²
Enrollment
64
Registered
2016-09-21
Start date
2015-03-02
Completion date
2017-07-11
Last updated
2018-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sickle Cell Disease

Brief summary

The aim of this study is to evaluate determinants of cerebral oxygenation and perfusion at the microcirculatory level in children with sickle cell anemia (SCA) using combined novel investigational tools: Arterial Spin Labeling (ASL) perfusion MR (Magnetic Resonnance) imaging, brain Near Infra-Red Spectroscopy (NIRS) and red blood cell (RBC) rheological properties.

Detailed description

The investigators hypothesize that brain perfusion and/or oxygenation modifications may be evidenced in SCA children who have no microarteriopathy and may correlate with hemorheological abnormalities and impaired vasomotion. A multimodal approach designed to study a. cerebral perfusion and oxygenation, b. flow motion properties and c. blood rheological parameters might help to describe the different processes involved in cerebral ischemia.

Interventions

PROCEDUREPhysical exams and blood analyzes

Blood samples collection (for DNA, plasma and cells analyzes) ; Hemorheologic analyzes ; ASL sequence on MRI ; Near Infra Red Spectroscopy (NIRS) and associated cardiofrequency analyze.

Sponsors

Hopital Universitaire Robert-Debre
CollaboratorOTHER
Imagine Institute
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* SS or S-beta° genotype; * age 6-16 years; * steady state; * normal TCD (Transcranial Doppler); * parental study approval and written informed consent.

Exclusion criteria

* SC, Sbeta+, SD Punjab genotype * history of overt stroke, * intracranial or cervical arterial stenosis, * abnormal TCD at the time of the study.

Design outcomes

Primary

MeasureTime frameDescription
Number of patients on which we detect default of cerebral perfusion (in order to correlate them with other clinical or biological parameters)1.5 yearsASL sequence (duration 4 min) : Regional brain tissue perfusion (expressed in mL/min/100g of tissue) will be measured in different lobes in both hemispheres and in the cerebellum. Pattern of perfusion will be analysed and measured.

Secondary

MeasureTime frameDescription
Bifrontal cerebral hemoglobin oxygen saturation1.5 yearsBifrontal cerebral hemoglobin oxygen saturation monitored by NIRS (15 min). Spectral analyses (Fourrier transform) will be used to analyze the brain microvascular oxygen variability and calculate the flowmotion and vasomotion activities.
Description of the global assessment of RBC deformability1.5 yearsThe description of the global assessment of RBC deformability will be done via a global association of several biological parameters : RBC deformability at several shear stresses by ektacytometry, RBC aggregation properties by syllectometry and blood viscosity by cone-plate viscosimetry. Measurements will be made according to the international guidelines for standardisation in hemorheology and within 4/5 hrs of sampling

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026